Cancer Immune Therapy Edited by G. Stuhler and P. Walden ...

152 7 Immunosuppresive Factors in Cancer
difluoromethylornithine in lung metastases
before and after surgery of primary
adenocarcinoma tumors in mice.
Biol. Cell 53: 33.
273 Sunkara, P. S. and A. L. Rosenberger.
1987. Antimetastatic activity of dl-a-difluoromethylornithine,
an inhibitor of
polyamine biosynthesis, in mice. Cancer
Res. 47: 933.
274 Marx, M., C. M. J. Townsend,
S. C. Barranco, E. J. Glass and
J. C. Thompson. 1987. Treatment of
hamster pancreatic cancer with a-difluoromethylornithine,
an inhibitor of
polyamine biosynthesis. J. Natl Cancer
Inst. 79: 543.
275 Upp, J. R. J., R. D. Beauchamp, C. M. J.
Townsend, S. C. Barranco, P. Singh,
S. Rajaraman, E. James and J. C. Thompson.
1988. Inhibition of human gastric
adenocarcinoma xenograft growth in
nude mice by a-difluoromethylornithine.
Cancer Res. 48: 3265.
276 Prakash, N. J., T. L. Bowlin, G. F. Davis,
P. S. Sunkara and A. Sjoerdsma.
1988. Antitumor activity of norspermidine,
a structural homologue of the natural
polyamine spermidine. Anticancer
Res. 8: 563.
277 Andersson, G. and O. Heby. 1977. Population
kinetics of an Ehrlich ascites
tumor following treatment with methylglyoxal-bis(guanylhydrazone),
a polyamine
synthesis inhibitor. Cancer Lett. 3:
59.
278 Luk, G. D., G. Goodwin, L. J. Marton
and S. B. Baylin. 1981. Polyamines are
necessary for the survival of human
small-cell lung carcinoma in culture.
Proc. Natl Acad. Sci. USA 78: 2355.
279 Manni, A. and C. Wright. 1983. Effect
of tamoxifen and a-difluoromethylornithine
on clones of nitrosomethylureainduced
rat mammary tumor cells
grown in soft agar culture. Cancer Res.
43: 1084.
280 Manni, A. and C. Wright. 1984. Reversal
of the antiproliferative effect of
the antiestrogen tamoxifen by polyamines
in breast cancer cells. Endocrinology
114: 836.
281 Seidenfeld, J., A. L. Block, K. A. Komar
and M. F. Naujokas. 1986. Altered
cell cycle phase distributions in cul-
tured human carcinoma cells partially
depleted of polyamines by treatment
with difluoromethylornithine. Cancer
Res. 46: 47.
282 Sunkara, P. S., C. C. Chang, N. J. Prakash
and P. J. Lachmann. 1985. Effect
of inhibition of polyamine biosynthesis
by dl-a-difluoromethylornithine on the
growth and melanogenesis of B16 melanoma
in vitro and in vivo. Cancer Res.
45: 4067.
283 Wallon, U. M., L. R. Shassetz,
A. E. Cress, G. T. Bowden and E. W. Gerner.
1994. Polyamine-dependent expression
of the matrix metalloproteinase matrilysin
in a human colon cancer-derived
cell line. Mol. Carcinogen. 11: 138.
284 Kubota, S., H. Kiyosawa,Y. Nomura, T.
Yamada and Y. Seyama. 1997. Ornithine
decarboxylase overexpression in mouse
10T1/2 fibroblasts: cellular transformation
and invasion. J. Natl Cancer Inst.
89: 567.
285 McCloskey, D. E., J. Yang, P. M.Woster,
N. E. Davidson and R. A. J. Casero.
1996. Polyamine analogue induction of
programmed cell death in human lung
tumor cells. Clin. Cancer Res. 2: 441.
286 Kaneko, H., H. Hibasami, K. Mori,
Y. Kawarada and K. Nakashima. 1998.
Apoptosis induction in human breast
cancer MRK-nu-1 cells by a polyamine
synthesis inhibitor, methylglyoxal bis
(cyclopentylamidino-hydrazone)
(MGBCP). Anticancer Res. 18: 891.
287 Holtta, E., M. Auvinen and L. C. Andersson.
1993. Polyamines are essential
for cell transformation by pp60vsrc:
delineation of molecular events relevant
for the transformed phenotype.
J. Cell Biol. 122: 903.
288 Tabib, A. and U. Bachrach. 1998. Polyamines
induce malignant transformation
in cultured NIH 3T3 fibroblasts.
Int. J. Biochem. Cell Biol. 30: 135.
289 Tabib, A. and U. Bachrach. 1999. Role
of polyamines in mediating malignant
transformation and oncogene expression.
Int. J. Biochem. Cell Biol. 31: 1289.
290 Iwata, S.,Y. Sato, M. Asada, M. Takagi,
A. Tsujimoto, T. Inaba, T. Yamada,
S. Sakamoto, J. Yata, T. Shimogori,
K. Igarashi and S. Mizutani. 1999.
Anti-tumor activity of antizyme which